HU9600442D0 - Nigella sativa as a medicinal treatment - Google Patents

Nigella sativa as a medicinal treatment

Info

Publication number
HU9600442D0
HU9600442D0 HU9600442A HU9600442A HU9600442D0 HU 9600442 D0 HU9600442 D0 HU 9600442D0 HU 9600442 A HU9600442 A HU 9600442A HU 9600442 A HU9600442 A HU 9600442A HU 9600442 D0 HU9600442 D0 HU 9600442D0
Authority
HU
Hungary
Prior art keywords
nigella sativa
medicinal treatment
sativa
medicinal
nigella
Prior art date
Application number
HU9600442A
Other languages
Hungarian (hu)
Other versions
HUT74226A (en
HU226319B1 (en
Inventor
Rajko D Medenica
Original Assignee
Medenica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medenica filed Critical Medenica
Publication of HU9600442D0 publication Critical patent/HU9600442D0/en
Publication of HUT74226A publication Critical patent/HUT74226A/en
Publication of HU226319B1 publication Critical patent/HU226319B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical composition containing an extract of the plant Nigella sativa is disclosed for treating cancer, preventing the side effects of anticancer chemotherapy, and for increasing the immune function in humans.
HU9600442A 1993-08-25 1994-08-25 Anticancer medicinal composition comprising nigella sativa extract and use of the active component of said extract in the manufacture of a medicament HU226319B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/111,631 US5482711A (en) 1993-08-25 1993-08-25 Use of Nigella sativa to increase immune function
PCT/US1994/009660 WO1995005839A1 (en) 1993-08-25 1994-08-25 Nigella sativa as a medicinal treatment

Publications (3)

Publication Number Publication Date
HU9600442D0 true HU9600442D0 (en) 1996-04-29
HUT74226A HUT74226A (en) 1996-11-28
HU226319B1 HU226319B1 (en) 2008-08-28

Family

ID=22339582

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600442A HU226319B1 (en) 1993-08-25 1994-08-25 Anticancer medicinal composition comprising nigella sativa extract and use of the active component of said extract in the manufacture of a medicament

Country Status (12)

Country Link
US (2) US5482711A (en)
EP (1) EP0804212B1 (en)
AT (1) ATE392902T1 (en)
AU (1) AU7868794A (en)
BR (1) BR9407362A (en)
CA (1) CA2169956A1 (en)
DE (1) DE69435091D1 (en)
HU (1) HU226319B1 (en)
OA (1) OA10572A (en)
PL (1) PL182890B1 (en)
SI (1) SI9420054B (en)
WO (1) WO1995005839A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1009579A5 (en) * 1996-07-04 1997-05-06 Ismail Mohamed Tejeddine Vibrating system for protection against radiation interference emitted by viewing screens and/or other sources of radiation, bio-energy balancing and geo-biological harmonisation or bio-cleaning of work places and homes
US6042834A (en) * 1997-01-29 2000-03-28 Baraka; Mohamed Wasif Herbal composition for diabetes and method of treatment
CA2283753C (en) * 1997-03-20 2005-10-11 Allen C. Barnes Micropathological patient replica based on unadulterated whole blood
KR100239879B1 (en) * 1997-11-05 2000-02-01 김상조 Crude drug composition for treatment and prevention of liver cancer
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US6231866B1 (en) 1998-04-30 2001-05-15 Douglas G. Mann Infused vegetable, fruit, herb, and/or seed fiber product and dietary supplements containing same
US6218434B1 (en) 1998-05-28 2001-04-17 University Of Kentucky Research Foundation Use of the naturally-occurring quinones thymoquinone and dithymoquinone as antineoplastic and cytotoxic agents
DE19844022C1 (en) * 1998-09-25 2000-05-25 Sherif Sabry Ragab Mekkawi Use of iron-binding glycoproteins and/or 10-hydroxy-2-decenoic acid in combination with thymoquinone for treating immunodeficiency diseases
GB2348132B (en) * 1999-03-02 2004-08-04 Nedaa Abdul-Ghani Nasif Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils
GB9904777D0 (en) 1999-03-02 1999-04-28 Nassief Nida A Novel method, an asthma therapy that act on eosinophils and/or t-lymphocytes
GB2347859B (en) * 1999-03-19 2004-02-25 Yasin Nazir Karim Yakub Herbal compositions
RU2172322C1 (en) * 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Allopherones as immunomodulating peptides
US6948494B1 (en) * 2000-05-10 2005-09-27 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet and method of use
WO2003075685A2 (en) * 2002-03-12 2003-09-18 Council Of Scientific And Industrial Research Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
RU2005103235A (en) * 2002-07-09 2005-09-20 АЗАЗИ Шифа Абдо Саеед Ахмед АЛЬ (AE) NATURAL VEGETABLE ANTIBIOTIC FOR THE TREATMENT OF UPPER RESPIRATORY SYSTEM INFECTIONS AND VARIOUS ORGANISM DISEASES
US7744929B2 (en) * 2003-09-15 2010-06-29 Ambotan Pharma, Llc Botanical drug compositions for treatments of liver and immunological disorders
US20050214393A1 (en) * 2004-03-26 2005-09-29 Osama Kandil Lipid fraction of Nigella sativa L. seeds
US7722906B2 (en) * 2004-03-26 2010-05-25 Biopharm Research & Development Corporation Limited Polyunsaturated fatty acid fractions of Nigella sativa L. seeds
US20090175970A1 (en) * 2005-01-26 2009-07-09 Veritron Limited Stabilized Plant Extract and Its Therapeutic Use
GB0501654D0 (en) * 2005-01-26 2005-03-02 Veritron Ltd Stabilised plant extract
CA2754719C (en) * 2006-08-10 2013-12-31 Allen C. Barnes Portable biological testing device and method
FR2922109B1 (en) 2007-10-16 2010-08-20 Bruno Eto PHARMACEUTICAL OR DIETETIC COMPOSITION FOR INHIBITING INTESTINAL ABSORPTION OF SUGAR.
CN109776669A (en) * 2018-12-29 2019-05-21 广州动物园 Brave interferon and its expressing gene, preparation method and application
US11260097B2 (en) 2020-07-06 2022-03-01 COVImmune Pharma LLC Immunomodulatory composition to treat and/or prevent COVID-19 illness

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687761A (en) * 1985-05-09 1987-08-18 Yaguang Liu Pharmaceutical composition for increasing immunity and decreasing side effects of anticancer chemotherapy
US4945115A (en) * 1985-05-09 1990-07-31 Yaguang Liu Process for preparing ferulic acid

Also Published As

Publication number Publication date
SI9420054B (en) 2008-10-31
CA2169956A1 (en) 1995-02-26
OA10572A (en) 2002-06-03
DE69435091D1 (en) 2008-06-05
HUT74226A (en) 1996-11-28
US5482711A (en) 1996-01-09
US5653981A (en) 1997-08-05
ATE392902T1 (en) 2008-05-15
AU7868794A (en) 1995-03-21
SI9420054A (en) 1997-02-28
WO1995005839A1 (en) 1995-03-02
HU226319B1 (en) 2008-08-28
PL313223A1 (en) 1996-06-10
EP0804212B1 (en) 2008-04-23
EP0804212A2 (en) 1997-11-05
BR9407362A (en) 1996-04-23
PL182890B1 (en) 2002-03-29

Similar Documents

Publication Publication Date Title
HU9600442D0 (en) Nigella sativa as a medicinal treatment
ZA928771B (en) Combination chemotherapy
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
GR3034535T3 (en) Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
IL110045A (en) Pharmaceutical compositions containing oligopeptides for combating AIDS and ARC and for immune stimulation and certain such novel oligopeptides
NZ258019A (en) Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract
NZ308789A (en) Tetralin derivatives and medicaments
FR08C0001I2 (en)
WO1995005839B1 (en) Nigella sativa as a medicinal treatment
AU4830097A (en) Use of an extract of Cimicifuga
ZA928140B (en) Compositions and methods for therapy and prevention of cancer, aids and anemia
AU5170499A (en) Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
EP0281070A3 (en) Pharmaceutical composition for the treatment of cancer
BG102667A (en) Diosgenine-containing composition
IL143012A0 (en) Pharmaceutical composition comprising an anti-cancer agent and at least one peptide
MD798G2 (en) Method of the mamma cancer treatment
AU4042795A (en) Treatment of non-small cell lung carcinoma
DE3163920D1 (en) Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases
ZA837972B (en) Method of analgesic treatment and pharmaceutical compositions
CA2103708A1 (en) Treatment of ovarian cancer
OA09771A (en) Asphodelus composition for increasing white blood cell count.
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: HIS EXCELLENCY GHASSAN I SHAKER, GBGB9A MITSUI CHE

MM4A Lapse of definitive patent protection due to non-payment of fees